Acurx Pharmaceuticals, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Acurx Pharmaceuticals, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Acurx Pharmaceuticals, Inc. made a loss over the last year. Acurx Pharmaceuticals, Inc. owes $0.26 for every $1 it owns. Acurx Pharmaceuticals, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAcurx Pharmaceuticals, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.78The share price is 0.78 times Acurx Pharmaceuticals, Inc.'s book value per share, lower than 85% of Healthcare companies in United States.
Market cap
$6 MThe total market value of all of Acurx Pharmaceuticals, Inc.'s shares at today's price (share price × number of shares), smaller than 91% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$8 MWhat Acurx Pharmaceuticals, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.47Net worth divided by the number of shares. The share price of $1.14 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-128.1%Acurx Pharmaceuticals, Inc. lost 128.1% of its shareholders' money over the last year, lower than 77% of Healthcare companies in United States.
Owes vs Owns
0.26×Acurx Pharmaceuticals, Inc. owes $0.26 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.
Dividend yield
NoneAcurx Pharmaceuticals, Inc. does not currently pay a dividend.
Profit growth
LossAcurx Pharmaceuticals, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Acurx Pharmaceuticals, Inc.: $6 M ÷ $8 M (30 Jun 2026) = 0.8.
What is Acurx Pharmaceuticals, Inc.'s return on equity?
Acurx Pharmaceuticals, Inc. lost 128.1% of its shareholders' money over the last year, lower than 77% of Healthcare companies in United States.
How much does Acurx Pharmaceuticals, Inc. owe compared with what it owns?
Acurx Pharmaceuticals, Inc. owes $0.26 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.
Does Acurx Pharmaceuticals, Inc. pay a dividend?
No. Acurx Pharmaceuticals, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.